Monday, February 9, 2026

Everything depends on the dividend stocks you pick

I'm not 100% sure....

But people seem to think Albert Einstein crowned compound interest as the 8th wonder of the world.

And although I doubt that's what the ol' genius concerned himself with...

Compound interest is arguably the most broken investing hack we've seen.

You'll never really understand what can happen in 10 years until you watch your money accumulate in that time. 

And I can't think of a better way to see this in action than through investing in dividend stocks.

Picking the right stocks automatically puts you in a position to reap a lot more than you've sown overtime.

But one wrong stock, and it's game over for your entire portfolio.

That's why I've been trying to get the 5 Dividend Investing Cheat Sheets into your hands…

In there, you'll see every single thing I'd consider before I even touch any stock for dividends.

You'll also see the 2 stocks I'm pouring $50,000 of my own money into.

Of course I can't make absolute guarantees here...

But your best bet is to grab the 5 Dividend Investing Cheat Sheets and look through it before throwing money at any stock.

Better yet, go here and get it now while it's still available at no cost.
By clicking the link above you agree to periodic updates from ProsperityPub and its partners (privacy policy)


 
 
 
 
 
 

More Reading from MarketBeat

Tesla Kills Legacy Models: Analyst Response Is Meh

Submitted by Thomas Hughes. Posted: 1/30/2026.

Red Tesla EV plugged into a Supercharger with Tesla logo, highlighting the company’s EV business pivot.

Article Highlights

  • Tesla’s plan to pause Model S and Model X production is likely a small revenue hit but could meaningfully change the margin mix.
  • The Optimus robots pivot could create a new growth pillar, but it also raises near-term execution, CapEx, and cash-burn risks.
  • Analyst targets remain mixed, and institutional buying may be a key swing factor for the stock’s direction in 2026.

Tesla (NASDAQ: TSLA) grabbed the market's attention when it revealed plans to shift gears: mothball Model S and Model X production and retool its Fremont facility to build robots.

Plans for 2026 call for limited sales of Optimus robots by year-end, with production ramping in 2027. The company aims to produce 1 million robots a year at roughly $30,000 each, equivalent to about $30 billion in annualized revenue. For shareholders, the announcement raised as many questions as it answered—chiefly what the move will mean for the stock.

Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks

The market is in freefall—and Trump's new tariffs just lit the fuse.

Millions of investors are blindsided as stocks plunge… but this is only Phase 1.

If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrowtc pixel

The impact on revenue is likely to be marginal, while the impact on margin could be substantial. Models S and X were higher-cost, lower-volume vehicles, comprising less than 3% of total automotive sales in 2025.

While the company's total automotive sales declined in the low double digits in 2025, Model S and X volumes fell roughly 50% and 30%, respectively.

Removing those models from the mix should shift sales toward higher-margin vehicles such as the Model Y and Model 3, and it also opens the door to a new growth pillar: robots.

The projected $30 billion in annualized robot revenue represents nearly 30% growth versus the 2026 consensus forecast.

Near-term impacts noted on the recent earnings call include higher CapEx and margin impairment. How long those effects will last depends on execution and technological progress and could exceed Tesla's 18- to 24-month production-ramp estimate.

The key risk for investors is that margin compression and cash burn persist for 24 months or longer before meaningful Optimus revenue is realized, which would weigh on profitability and the stock's upside potential.

Investors should also note that Tesla has not yet sold any functional robots—aside from a toy in the Tesla store.

Tesla Catalyzes an Analyst Reset With Optimus News

MarketBeat tracked 16 analyst revisions within 36 hours of the announcement, but sentiment remains mixed, which could cap near-term gains. Roughly as many analysts lowered price targets as raised them, and several set targets below consensus. As a result, the consensus rating remains a Hold, albeit with a modest bullish tilt.

Additionally, a sizable number of analysts rate the stock a Sell, and the consensus price target has declined. That target implies fair value near $410—well below key resistance levels—and several forecasts sit in the $125 to $325 range.

Institutions could be the deciding factor in whether TSLA reaches a new high in 2026.

Data shows institutional owners aggressively accumulated shares in 2025 and early 2026; activity has since decelerated and is at a long-term low. If that trend continues, institutions could shift from accumulation to distribution, reinforcing the analyst-implied price cap. If accumulation resumes, reduced share availability could support higher prices.

Catalyst and Risks for Tesla in 2026

Tesla's 2026 catalysts carry as much risk as potential reward. Key items include the expansion of robotaxi services in Austin and the start of commercial robotaxi production. Progress is slow but ongoing, and Tesla says fully 100% autonomous driving is now available. Cybercab production is expected in the first half of the year, followed by what CEO Elon Musk calls a "painfully slow" ramp as demand for autonomous rides increases.

TSLA stock chart displaying a seemingly capped rally.

Tesla's post-release price action underscores those risks. The stock has struggled at resistance for five months and fell sharply after its October earnings report, before finding support. It is now approaching the 150-day moving average—a make-or-break technical level for many long-term investors. A decisive break below that average could trigger distribution and further selling; analysts say the stock could fall to around $360 or lower if that level fails, making near-term price action a critical risk to monitor.


 

 
This email content is a sponsored message for ProsperityPub, a third-party advertiser of MarketBeat. Why was I sent this email?.
 
If you have questions or concerns about your subscription, please contact MarketBeat's South Dakota based support team at contact@marketbeat.com.
 
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
 
Copyright 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl. #620, Sioux Falls, South Dakota 57103. USA..
 
Further Reading: Trump's Final Shocking Act Begins February 24 (From Banyan Hill Publishing)

No comments:

Post a Comment

From Quiet Compounder to 2026 Breakout? BSEM

Bio Stem Technologies Accelerates Into 2026 With Transformative Acquisition, Seven Straight Profitable Quarters, and Entry into Advanced and...